Filing Details
- Accession Number:
- 0001104659-20-118221
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-26 17:27:07
- Reporting Period:
- 2020-10-26
- Accepted Time:
- 2020-10-26 17:27:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 884121 | Tekla Life Sciences Investors | HQL | (0) | 043147016 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1254774 | R Daniel Omstead | C/O Tekla Life Sciences Investors 100 Federal Street, 19Th Floor Boston MA 02110 | President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Shares Of Beneficial Interest | Acquisiton | 2020-10-26 | 6,175 | $17.52 | 131,836 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
